Protalix BioTherapeutics (PLX) – Earnings
-
Protalix BioTherapeutics (PLX) Reports In-Line Q3 EPS
-
Protalix BioTherapeutics (PLX) Reports Q2 Loss of $0.16
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PLX Stock Lookup